Evidence map›Paper›PMID 32206922›Full record

ArticleJournal of materials science. Materials in medicine2020

Bioprinting predifferentiated adipose-derived mesenchymal stem cell spheroids with methacrylated gelatin ink for adipose tissue engineering.

Julien Colle, Phillip Blondeel, Axelle De Bruyne, Silke Bochar, Liesbeth Tytgat, Chris Vercruysse, Sandra Van Vlierberghe, Peter Dubruel, Heidi Declercq

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julien ColleTissue Engineering Group, Bioprint Facility-Department of Human Structure and Repair-Faculty of Medicine and Health Sciences, Gent University, Corneel Heymanslaan 10 (6B3), 9000, Gent, Belgium. julien.colle@ugent.be.
Phillip BlondeelDepartment of Plastic Surgery, University Hospital Gent, Gent, Belgium.
Axelle De BruyneTissue Engineering Group, Bioprint Facility-Department of Human Structure and Repair-Faculty of Medicine and Health Sciences, Gent University, Corneel Heymanslaan 10 (6B3), 9000, Gent, Belgium.
Silke BocharTissue Engineering Group, Bioprint Facility-Department of Human Structure and Repair-Faculty of Medicine and Health Sciences, Gent University, Corneel Heymanslaan 10 (6B3), 9000, Gent, Belgium.
Liesbeth TytgatPolymer Chemistry and Biomaterials Group, Department of Organic Chemistry, Faculty of Sciences, Gent University, Krijgslaan 281, 9000, Gent, Belgium.
Chris VercruysseTissue Engineering Group, Bioprint Facility-Department of Human Structure and Repair-Faculty of Medicine and Health Sciences, Gent University, Corneel Heymanslaan 10 (6B3), 9000, Gent, Belgium.
Sandra Van VlierberghePolymer Chemistry and Biomaterials Group, Department of Organic Chemistry, Faculty of Sciences, Gent University, Krijgslaan 281, 9000, Gent, Belgium.
Peter DubruelPolymer Chemistry and Biomaterials Group, Department of Organic Chemistry, Faculty of Sciences, Gent University, Krijgslaan 281, 9000, Gent, Belgium.
Heidi DeclercqTissue Engineering Group, Bioprint Facility-Department of Human Structure and Repair-Faculty of Medicine and Health Sciences, Gent University, Corneel Heymanslaan 10 (6B3), 9000, Gent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing number of mastectomies results in a greater demand for breast reconstruction characterized by simplicity and a low complication profile. Reconstructive surgeons are investigating tissue engineering (TE) strategies to overcome the current surgical drawbacks. 3D bioprinting is the rising technique for the fabrication of large tissue constructs which provides a potential solution for unmet clinical needs in breast reconstruction building on decades of experience in autologous fat grafting, adipose-derived mesenchymal stem cell (ASC) biology and TE. A scaffold was bioprinted using encapsulated ASC spheroids in methacrylated gelatin ink (GelMA). Uniform ASC spheroids with an ideal geometry and diameter for bioprinting were formed, using a high-throughput non-adhesive agarose microwell system. ASC spheroids in adipogenic differentiation medium (ADM) were evaluated through live/dead staining, histology (HE, Oil Red O), TEM and RT-qPCR. Viable spheroids were obtained for up to 14 days post-printing and showed multilocular microvacuoles and successful differentiation toward mature adipocytes shown by gene expression analysis. Moreover, spheroids were able to assemble at random in GelMA, creating a macrotissue. Combining the advantage of microtissues to self-assemble and the controlled organization by bioprinting technologies, these ASC spheroids can be useful as building blocks for the engineering of soft tissue implants.

Indexed as

Adipose TissueBioprintingGelatinInkMesenchymal Stem CellsSpheroids, CellularTissue EngineeringGelatin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.